In vivo quantitation of rare circulating tumor cells by multiphoton intravital flow cytometry

Wei He, Haifeng Wang, Lynn C. Hartmann, Ji Xin Cheng, Philip S. Low

Research output: Contribution to journalArticle

207 Citations (Scopus)

Abstract

Quantitation of circulating tumor cells (CTCs) constitutes an emerging tool for the diagnosis and staging of cancer, assessment of response to therapy, and evaluation of residual disease after surgery. Unfortunately, no existing technology has the sensitivity to measure the low numbers of tumor cells (<1 CTC per ml of whole blood) that characterize minimal levels of disease. We present a method, intravital flow cytometry, that noninvasively counts rare CTCs in vivo as they flow through the peripheral vasculature. The method involves i.v. injection of a tumor-specific fluorescent ligand followed by multiphoton fluorescence imaging of superficial blood vessels to quantitate the flowing CTCs. Studies in mice with metastatic tumors demonstrate that CTCs can be quantitated weeks before metastatic disease is detected by other means. Analysis of whole blood samples from cancer patients further establishes that human CTCs can be selectively labeled and quantitated when present at ≈2 CTCs per ml, opening opportunities for earlier assessment of metastatic disease.

Original languageEnglish (US)
Pages (from-to)11760-11765
Number of pages6
JournalProceedings of the National Academy of Sciences of the United States of America
Volume104
Issue number28
DOIs
StatePublished - Jul 10 2007

Fingerprint

Circulating Neoplastic Cells
Flow Cytometry
Neoplasms
Neoplasm Staging
Optical Imaging
Blood Vessels
Cell Count
Ligands
Technology
Injections

Keywords

  • Cancer diagnosis
  • Folate conjugates
  • In vivo imaging
  • Metastasis
  • Multiphoton microscopy

ASJC Scopus subject areas

  • Genetics
  • General

Cite this

In vivo quantitation of rare circulating tumor cells by multiphoton intravital flow cytometry. / He, Wei; Wang, Haifeng; Hartmann, Lynn C.; Cheng, Ji Xin; Low, Philip S.

In: Proceedings of the National Academy of Sciences of the United States of America, Vol. 104, No. 28, 10.07.2007, p. 11760-11765.

Research output: Contribution to journalArticle

He, Wei ; Wang, Haifeng ; Hartmann, Lynn C. ; Cheng, Ji Xin ; Low, Philip S. / In vivo quantitation of rare circulating tumor cells by multiphoton intravital flow cytometry. In: Proceedings of the National Academy of Sciences of the United States of America. 2007 ; Vol. 104, No. 28. pp. 11760-11765.
@article{1f386675b6da4cbf9f16ad46204a3bf1,
title = "In vivo quantitation of rare circulating tumor cells by multiphoton intravital flow cytometry",
abstract = "Quantitation of circulating tumor cells (CTCs) constitutes an emerging tool for the diagnosis and staging of cancer, assessment of response to therapy, and evaluation of residual disease after surgery. Unfortunately, no existing technology has the sensitivity to measure the low numbers of tumor cells (<1 CTC per ml of whole blood) that characterize minimal levels of disease. We present a method, intravital flow cytometry, that noninvasively counts rare CTCs in vivo as they flow through the peripheral vasculature. The method involves i.v. injection of a tumor-specific fluorescent ligand followed by multiphoton fluorescence imaging of superficial blood vessels to quantitate the flowing CTCs. Studies in mice with metastatic tumors demonstrate that CTCs can be quantitated weeks before metastatic disease is detected by other means. Analysis of whole blood samples from cancer patients further establishes that human CTCs can be selectively labeled and quantitated when present at ≈2 CTCs per ml, opening opportunities for earlier assessment of metastatic disease.",
keywords = "Cancer diagnosis, Folate conjugates, In vivo imaging, Metastasis, Multiphoton microscopy",
author = "Wei He and Haifeng Wang and Hartmann, {Lynn C.} and Cheng, {Ji Xin} and Low, {Philip S.}",
year = "2007",
month = "7",
day = "10",
doi = "10.1073/pnas.0703875104",
language = "English (US)",
volume = "104",
pages = "11760--11765",
journal = "Proceedings of the National Academy of Sciences of the United States of America",
issn = "0027-8424",
number = "28",

}

TY - JOUR

T1 - In vivo quantitation of rare circulating tumor cells by multiphoton intravital flow cytometry

AU - He, Wei

AU - Wang, Haifeng

AU - Hartmann, Lynn C.

AU - Cheng, Ji Xin

AU - Low, Philip S.

PY - 2007/7/10

Y1 - 2007/7/10

N2 - Quantitation of circulating tumor cells (CTCs) constitutes an emerging tool for the diagnosis and staging of cancer, assessment of response to therapy, and evaluation of residual disease after surgery. Unfortunately, no existing technology has the sensitivity to measure the low numbers of tumor cells (<1 CTC per ml of whole blood) that characterize minimal levels of disease. We present a method, intravital flow cytometry, that noninvasively counts rare CTCs in vivo as they flow through the peripheral vasculature. The method involves i.v. injection of a tumor-specific fluorescent ligand followed by multiphoton fluorescence imaging of superficial blood vessels to quantitate the flowing CTCs. Studies in mice with metastatic tumors demonstrate that CTCs can be quantitated weeks before metastatic disease is detected by other means. Analysis of whole blood samples from cancer patients further establishes that human CTCs can be selectively labeled and quantitated when present at ≈2 CTCs per ml, opening opportunities for earlier assessment of metastatic disease.

AB - Quantitation of circulating tumor cells (CTCs) constitutes an emerging tool for the diagnosis and staging of cancer, assessment of response to therapy, and evaluation of residual disease after surgery. Unfortunately, no existing technology has the sensitivity to measure the low numbers of tumor cells (<1 CTC per ml of whole blood) that characterize minimal levels of disease. We present a method, intravital flow cytometry, that noninvasively counts rare CTCs in vivo as they flow through the peripheral vasculature. The method involves i.v. injection of a tumor-specific fluorescent ligand followed by multiphoton fluorescence imaging of superficial blood vessels to quantitate the flowing CTCs. Studies in mice with metastatic tumors demonstrate that CTCs can be quantitated weeks before metastatic disease is detected by other means. Analysis of whole blood samples from cancer patients further establishes that human CTCs can be selectively labeled and quantitated when present at ≈2 CTCs per ml, opening opportunities for earlier assessment of metastatic disease.

KW - Cancer diagnosis

KW - Folate conjugates

KW - In vivo imaging

KW - Metastasis

KW - Multiphoton microscopy

UR - http://www.scopus.com/inward/record.url?scp=34547487297&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34547487297&partnerID=8YFLogxK

U2 - 10.1073/pnas.0703875104

DO - 10.1073/pnas.0703875104

M3 - Article

C2 - 17601776

AN - SCOPUS:34547487297

VL - 104

SP - 11760

EP - 11765

JO - Proceedings of the National Academy of Sciences of the United States of America

JF - Proceedings of the National Academy of Sciences of the United States of America

SN - 0027-8424

IS - 28

ER -